Sunshine Biopharma (SBFM) Net Margin (2015 - 2026)
Sunshine Biopharma (SBFM) posted Net Margin of 15.38% for Q1 2026, up 38.39% on a QoQ basis from 24.96% in Q4 2025, and down 212.0% year-over-year from 13.73% in Q1 2025.
Sunshine Biopharma (SBFM) Net Margin (2015 - 2026) Analysis & Trends
Sunshine Biopharma's Net Margin history runs 9 years deep, the most recent figure standing at 15.38% for Q1 2026.
- Quarterly Net Margin fell 212.0% year-over-year to 15.38% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 17.02% (up 41.0% YoY) and the FY2025 annual result came in at 16.46%, down 174.0% from the prior year.
- Net Margin was 15.38% for Q1 2026 at Sunshine Biopharma, up from 24.96% in the prior quarter.
- Across five years, Net Margin topped out at 3.14% in Q3 2025 and bottomed at 1097.09% in Q3 2022.
- A 5-year average of 193.69% and a median of 19.11% in 2024 frame the typical range for Net Margin.
- Peak annual rise in Net Margin reached 1443245 bps in 2022, while the deepest fall reached 138054 bps in 2022.
- Sunshine Biopharma's Net Margin stood at 596.78% in 2022, then jumped by 97 bps to 15.78% in 2023, then sank by 43 bps to 22.49% in 2024, then decreased by 11 bps to 24.96% in 2025, then soared by 38 bps to 15.38% in 2026.
- Business Quant data shows SBFM's Net Margin at 15.38% in Q1 2026, 24.96% in Q4 2025, and 3.14% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 91.98 Bn | 90.11 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.92 Bn | 32.18 Bn | 1.97 Bn | 9.29% |
| 3 | Zoetis | 32.99 Bn | 31.05 Bn | 1.62 Bn | 26.57% |
| 4 | Takeda Pharmaceutical | 27.75 Bn | 23.69 Bn | 4.39 Bn | -33.66% |
| 5 | United Therapeutics | 23.03 Bn | 20.87 Bn | 648.10 Mn | 35.18% |
| 6 | RedHill Biopharma | 21.80 Bn | 21.80 Bn | - | - |
| 7 | Viatris | 20.51 Bn | 18.70 Bn | 1.16 Bn | 5.03% |
| 8 | Neurocrine Biosciences | 18.10 Bn | 16.78 Bn | 800.70 Mn | 24.30% |
| 9 | Elanco Animal Health | 12.77 Bn | 12.34 Bn | 785.00 Mn | 4.16% |
| 10 | Sunshine Biopharma | 696,643.46 | -6.22 Mn | 2.18 Mn | -15.38% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -15.38% |
| Dec 31, 2025 | -24.96% |
| Sep 30, 2025 | 3.14% |
| Jun 30, 2025 | -31.36% |
| Mar 31, 2025 | -13.25% |
| Dec 31, 2024 | -22.49% |
| Sep 30, 2024 | -14.20% |
| Jun 30, 2024 | -19.11% |
| Mar 31, 2024 | -17.02% |
| Dec 31, 2023 | -15.78% |
| Sep 30, 2023 | -10.94% |
| Jun 30, 2023 | -16.22% |
| Mar 31, 2023 | -34.79% |
| Dec 31, 2022 | -596.78% |
| Sep 30, 2022 | -1,097.09% |
| Jun 30, 2022 | -358.51% |
| Mar 31, 2022 | -1,007.98% |
| Dec 31, 2021 | 783.75% |
| Sep 30, 2021 | -8,018.47% |
| Jun 30, 2021 | -5,445.12% |